Drug Trial Radar · NCT07581470
Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
198
Planned (sponsor's estimate)
Start
May 8, 2026
Primary completion
Jun 30, 2027
Study completion Jul 31, 2027
Sponsor
- Lead sponsor
- Poznan University of Medical SciencesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 12, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
his study will test whether giving dexamethasone through a vein can improve pain control after total hip replacement surgery. Dexamethasone is commonly used to reduce nausea and may also help with pain, but it is not clear which dose works best. Patients will be randomly assigned to receive either no dexamethasone, 4 mg, or 8 mg, in addition to standard anesthesia and a nerve block (PENG block). The main goal is to see how long patients go without needing additional pain medication after surgery. The study will also look at pain levels, use of opioid painkillers, nausea and vomiting, blood sugar levels, and possible side effects.
Conditions
- Osteoarthritis, Hip
- Hip Osteoarthritis
Interventions
Dexamethasone 4mgDrug
Intravenous dexamethasone administered as a single dose after induction of anesthesia, at doses of 4 mg
PlaceboDrug
Intravenous administration of 0.9% sodium chloride in a volume identical to active treatment, given after induction of anesthesia.
Dexamethasone 8mgDrug
Intravenous dexamethasone administered as a single dose after induction of anesthesia, at doses of 8 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Rescue AnalgesiaTime frame: 48 hours after surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Poznan University of Medical Sciences
Poznan, Poland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.